Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Saxenda is a daily injection and Wegovy, like Mounjaro, is a weekly injection. Mounjaro has shown more promising results, with a clinical trial finding participants lost up to 22.5% of their body fat.

Paul Curran, MPharm, a clinical pharmacist with Optimal You in the UK, says there is one nasty side effect, in particular, ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

A new Mounjaro user has opened up on their experience taking the drug - including the one side effect they're struggling with ...